Human genetic studies have long been vastly Eurocentric, raising a key question about 19 the generalizability of these study findings to other populations. Because humans 20 originated in Africa, these populations retain more genetic diversity, and yet individuals 21 of African descent have been tremendously underrepresented in genetic studies. The 22 diversity in Africa affords ample opportunities to improve fine-mapping resolution for 23 Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted:
associated loci, discover novel genetic associations with phenotypes, build more 1 generalizable genetic risk prediction models, and better understand the genetic 2 architecture of complex traits and diseases subject to varying environmental pressures. 3 Thus, it is both ethically and scientifically imperative that geneticists globally surmount 4 challenges that have limited progress in African genetic studies to date while 5 meaningfully including African investigators, as greater inclusivity and enhanced 6 research capacity affords enormous opportunities to accelerate genomic discoveries 7 that translate more effectively to all populations. We review the advantages and 8 challenges of studying the genetic architecture of complex traits and diseases in Africa. 9
For example, with greater genetic diversity comes greater ancestral heterogeneity; this 10 higher level of understudied diversity can yield novel genetic findings, but some 11 methods that assume homogeneous population structure and work well in European 12 negligibly from 0.57% to 3% [2] . This bias results in many medically relevant 1 consequences emanating from an interpretability gap that varies across ancestries [3, 4] . 2 For example, based on standard practice at leading genetic testing laboratories, African 3
Americans were more likely than European descent patients to be incorrectly told they 4 have a genetic mutation that increases their risk of hypertrophic cardiomyopathy, an 5 early-onset life-threatening heart disease [5] . Such genetic misdiagnoses are 6 preventable, the authors point out, with the inclusion of even a small number of 7 ancestry-matched controls [5] . Additionally, drug metabolism genes such as CYP3A4 8 contain mutations that alter dosage requirements (e.g., for warfarin); but with genetic 9 variation disproportionately uncatalogued in terms of frequency and clinical 10 consequence among African populations and individuals [6] , genotype-based dosage 11 adjustment would be less valuable than in Europeans. In the US, the National Human 12
Genome Research Institute (NHGRI) at the National Institutes of Health (NIH) has 13 emphasized the need to increase diversity in genetic studies [7] . This prioritization is an 14 important step that, if heeded, will aid interpretations in medical genomics for all 15 ethnicities (including Europeans) [8] . Greater inclusivity of African populations in 16 medical genomics endeavors is important for accelerating genomic discoveries, 17 enabling the reconstruction of modern human origins, producing results that can be 18 translated across populations more accurately, identifying genetic associations between 19 traits and genetic variation present in some populations but not others, and building 20 research capacity in Africa. These study biases have not happened in a vacuum (see "Existing challenges to 1 surmount for African genetics studies"), but have had widespread consequences for the 2 tools and resources available to perform GWAS in African populations. Genotyping 3 arrays, because they are often based on European sequencing resources, have 4 traditionally been biased towards alleles most frequent and imputable in European 5 populations [9, 10] , compounding biases in which GWAS identify associated variants 6 that are most common in the populations in which traits are studied [11, 12] . In contrast, 7 array backbones that prioritize SNPs that are polymorphic and maximize tagged 8 variants across all populations improve imputation performance, providing more even 9 genomic coverage [13] . Perhaps more importantly, the largest imputation panels are 10 vastly Eurocentric, which shortchanges representation of the greater haplotypic diversity 11 present in Africans as a consequence of more rapid linkage disequilibrium (LD) decay 12 from deeper recombination history [14, 15] Africa has been subjected to a long, violent, and oppressive colonial history that has 3 bred suspicion and an anticipation of exploitation of resources. This understandable 4 mistrust continues to create strain in ongoing relations, with new actors such as China 5 in addition to European groups scrambling for African resources [16, 17] . The impact on 6 research collaborations is evident, with some authors calling it 'neo-colonial science' 7 [18] . Such strained relations are more pronounced in collaborations involving genetic 8 studies, especially when shipping samples out of Africa and the Global South [19] . 9
Some authors argue for maintaining the 'genomic sovereignty' of Africans, emphasizing 10 the need to ensure such collaborations benefit Africans and address issues around 11 ownership of African genetic material [20] . Proponents of international collaborations 12 argue that working with high income countries will eventually ensure equity, justice, and 13 benefit to Africans, with capacity building for genomic research being an immediate 14 benefit for African institutions, although concerns have been raised about the 15 sustainability of these efforts [21] . Ongoing tensions weigh the big benefit to Africans 16 from the inclusion of more African DNA in global studies and African researchers 17 involved in these collaborations against the challenges of promoting science in Africa in 18 a way that accelerates the integration and importing of the best science around the 19 world into Africa. 20
21

Infrastructural 22
Conducting genetic studies in Africa is not an easy task. The infrastructural problems 1 range from unreliable or no electricity in clinics and laboratories that process samples, 2 through impassable roads in some rural areas, to crime or political instability making 3 some areas dangerous and/or inaccessible for researchers. Many African countries do 4 not have sufficient laboratory equipment or facilities for genomics research, and most 5 require imported reagents. Importing is not only a lengthy process, but also costly-6 reagents are often many times more expensive in Africa than Western countries in real 7 terms, not including shipment costs. There is also a lack of biobanks, partially due to 8 power interruptions affecting storage and processing of samples. There are African 9 institutions with experience in large-scale human genetic analyses, and the H3ABionet 10 consortium has developed further core bioinformatics infrastructure in Africa [22] . 11
However, high-speed internet connections and powerful computers are not always 12 available to access large data files. Human resources issues can also be a challenge, 13 namely lack of skilled personnel, high staff turnover with attrition due to inadequate pay, 14 and competing demands for time from qualified staff. Relatedly, brain drain is a major 15 issue, as many skilled African scientists leave the continent in search of greener 16 pastures [23, 24] . To be sensitive to these infrastructural challenges and the desire that 17
African-based researchers get the first opportunity to analyze their own genetic data, 18 some major international research initiatives such as H3Africa has required a relatively 19 long embargo period on publication reserved only for African researchers [25] . Further 20 efforts to connect African researchers to adequate computing power (e.g., wireless 21
connections to cloud computing) may offer more direct means to facilitate and 22 accelerate research. Compared with the relative ease of acquiring samples in areas 23 close to major research institutes, with reliable roads, power, and social structure, it is 1 no surprise that databanks have focused on European/white populations, but it is 2 scientifically and ethically imperative that geneticists rise to these challenges for the 3 benefit of all. 4
5
Funding 6
Genetic research is expensive, and a lack of attention from African policy makers in a 7 resource-limited setting (i.e. the entire African continent having only a third the GDP of 8 the United States) is primarily driven by competing priorities for more immediate public 9 health concerns including infectious diseases over inherited conditions [26, 27] . Data 10 generation is still the most expensive part of genomics, whereas data analysis is more 11 affordable and therefore a viable option for capacity building in resource-limited areas 12
[28]. Furthermore, journals from the developed world typically exist behind expensive 13 pay-walls that are not accessible to all researchers and do not always encourage 14 publication of work from the Global South, often returning manuscripts without review 15 citing a lack of "sufficient general interest." Having fewer publications has a knock-on 16 effect on future grant funding and attracting students. Gates Foundation has made massive investments to improve health in Africa, with 7 agricultural genetics being a key component of their development strategy. This 8 international support is essential for African geneticists to continue their research [21] . 9
10
Ethical 11
Ethics review boards may lack capacity and familiarity with genomics research, which 12 creates challenges for making informed decisions about long-term, large-scale 13 collaborative genetic studies that in turn can delay funded projects [28] . These 14 challenges are partially driven by restrictive ethical guidelines and uncertainty about the 15 benefits of such studies specifically to African populations [28] . Unlike in the US, 16 genetics projects are subject to ethics review both at the provincial and national levels 17 as a legacy of colonialism, but this can lead to long delays on the order of years. Ethics 18 approval by regulatory bodies in Africa is mostly restricted to project-specific research 19 questions, often raising questions around 'broad consent' and 'indefinite storage' of 20 samples that are not easy to answer. A primary concern about loss of control and 21 ownership over the DNA samples arises when they are shipped abroad [32] . 22
Burgeoning interest in building large-scale genomics collaborations in Africa has 23 resulted in a recent best practices ethical framework from H3Africa for genomics 1 research and biobanking in Africa [25] . Some communities have set up local councils to 2 oversee the research projects allowed in the community and the publications that result 3 from the research [33] . While these are excellent in theory, in practice there can be long 4 delays, misunderstanding due to unfamiliarity of lay people with scientific and genetic 5 terms, and a lack of continuity in leadership. Consequently, even when extensive 6 consultation on planned or existing research projects has taken place, this often needs 7
to be repeated at each subsequent visit. New council leaders sometimes try to enforce 8 sample destruction before allowing further sampling, even when consent forms specify 9 long sample storage. A middle ground of community members more familiar with 10 research methodology and terminology that is acceptable to the council would be the 11 ideal solution, but is not always feasible. Furthermore, while returning scientific 12 discoveries to communities or participants can and should be the norm, it is challenging 13 to re-contact study participants in less stable communities as people lose cell phones or 14 move for employment opportunities. 15
16
Respect and consent 17
To ensure mutual respect in collaborative studies of African genetics, it is important to 18 avoid generalizing "African-ness" in such a vast continent, comprising not only more 19 genetic diversity than the rest of the world, but also so many cultures, language groups, 20 and world views, some of which may be marginalized or discriminated against. 21
Consequently, it can be more challenging to establish and sustain multi-national African 22 collaborations than in the West. However, it is important to obtain diverse perspectives 23 from continental Africans when communicating science broadly. Furthermore, 1 meaningful engagement with African colleagues is vital to healthy collaborations and to 2 avoid tokenism. Additionally, obtaining informed consent for genomics research can be 3 complex in any setting, but poses even more of a challenge where there are lower 4 income and literacy levels or language barriers. Furthermore, some diseases such as 5 mental illness are subject to greater stigma in some African communities, requiring 6 culturally sensitive enrollment and awareness of differences from the U.S. and Europe. Communicating science respectfully can also be challenging when nomenclature is 14 subject to sociopolitical debate. The naming of the descendants of the original hunter-15 gatherers of Southern Africa is a case in point. In an attempt to be politically correct, 16 many population geneticists use the word "KhoeSan" to refer to the Khoe and San 17 groups collectively. However, the San Council of Southern Africa prefers to keep these 18 terms separate (i.e., San and Khoe or Nama) to denote the different cultural groups. 19 Many of the "San" individuals prefer being called "Bushmen," while others consider the 20 word to be pejorative. Labels are only useful insofar as they are universally informative, 21
and it is important to decide on labels that are acceptable to the communities and 22
investigators. Wide pre-publication consultation is obviously necessary to be respectful 1 of research participants [36] , but complete consensus is unlikely. 2 3 Genetic insights into population diversity, substructure, and origins in Africa 4 A clear understanding of African population structure is critical for the optimal design of 5 genotype-phenotype studies, with low-hanging opportunities currently available due to a 6 relative dearth of prior studies. Africa is the cradle of humanity, resulting globally in the 7 highest levels of genetic diversity within and between groups [37]. Continental-level 8 ancestral divergence has been impacted by demographically complex and regionally 9 distinct differences in admixture patterns with multiple hunter-gatherer, pastoralist, and 10
Eurasian populations [15, [38] [39] [40] [41] [42] , which is correlated with Afro-Asiatic, Nilo-Saharan, 11
Khoisan, and Niger-Congo linguistic families (Figure 1) [43]. This complexity has 12 hampered the investigation of health aspects likely to have a genetic basis, as fewer 13 studies have deeply characterized the genetic make-up of those populations. In South 14
Africa for example, efforts to admixture map tuberculosis susceptibility were waylaid for 15 years by a detour to disentangle the very complex admixture history of study 16 participants particularly given the relative dearth of reference genetic resources and 17 ancestry studies [44] . 18 
19
The most widespread ancestry component in Africa is among the Niger-Congo 20 language group, reflecting the Bantu Expansion [15] . This expansion of agro-pastoralist 21 groups during the past ~5,000 years led to coexistence, assimilation, and displacement Project has worked to ameliorate this gap, data access is somewhat more challenging 11 than e.g., the publicly available 1000 Genomes Project [15] . This difference in data 12 availability re-emphasizes the tension between protected access for African scientists 13 versus ensuring that African research and investigators are not left behind in global 14 genetics efforts. populations to be effective at controlling population structure, cryptic relatedness, and 9 further increase power in structured populations [74] [75] [76] [77] . Additionally, studies of 10 evolutionarily important traits such as malaria resistance may be further complicated by 11 high levels of genetic diversity in the parasite, multiple independent origins of resistance 12 loci, and allelic heterogeneity, necessitating specialized association approaches [78] . 13
These studies demonstrate that more advanced GWAS methods may be more fruitful 14 generally, but especially in Africa where higher rates of substructure are more typical 15 than in Europe. 16 
17
Advantages and opportunities for genetic architecture studies in Africa 18
While there are challenges to overcome for GWAS in Africa, the scientific and ethical 19 opportunities for doing these large-scale studies should not be discounted. Growing 20 inclusion of African American participants in large-scale medical genomics studies is 21 crucial, but still leaves behind many populations and large swaths of sub-Saharan 22
African genetic diversity, which may greatly increase our understanding of complex trait 23 genetic architecture [79] . There is more genetic and often phenotypic diversity in Africa 1 that has been understudied, meaning there is considerable low-hanging fruit that will 2 ensure novel findings and insights into the genetic architectures and etiologies of 3 complex traits. More rapid LD decay in Africa also means there is greater fine-mapping 4 resolution to pinpoint causal variants influencing traits than will be discovered in any 5 other global population common clinical lab tests will more easily ensure better prognostic value than existing 5 reference intervals [87] . In contrast, the most significant and highest frequency genetic 6 variants from GWAS used to predict genetic risk are not likely to be the same across 7 populations, even when the underlying causal variants are the same. This is due to 8 GWAS discovery biases, as variants used to predict risk tend to be more common and 9 explain more phenotypic variation in the study population. We are developing new 10 analytical methods that will help even the generalizability of genetic prediction accuracy 11 by considering LD within and between populations; however, the only way genetic 12 prediction power of inherited diseases in non-Europeans can truly be made equal is with 13 massive investments to produce similar-sized GWAS of these phenotypes in non-14 European populations. Additionally, discoveries based on African genetics contribute to 15 world knowledge, but most African population groups are sufficiently different that 16 insights made from trans-ethnic studies (e.g. European and East Asian) can similarly be 17 gained by analyzing multiple GWAS of different African populations. 18 
19
If one of the major missions of genetic analysis is to understand the biological basis and 20 evolutionary origins of diseases and traits and to use this knowledge to perform 21 biologically-informed drug discovery, human evolution tells us that Africa has a huge 22 role to play. Progress has so far been slower, but we emphasize that this is not due to 23 • This study used genotype data from 22 southern African populations to assess 6 fine-scale population structure, which was shown to have a complex relationship 7 with geography, ecology, language, and subsistence strategy. 
